Inactivation of the methicillin resistance gene mecA in vancomycin- resistant Staphylococcus aureus

Microbial Drug Resistance

Volumn 5, Issue 4, 1999, Pages 253-257

  Sieradzki, Krzysztof ^a   Wu, Shang Wei ^a   Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; ERYTHROMYCIN; METICILLIN; PENICILLIN BINDING PROTEIN; PLASMID VECTOR; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; FLUOROGRAPHY; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STOP CODON;

PROKARYOTA; STAPHYLOCOCCUS AUREUS;

EID: 0033391363     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1999.5.253     Document Type: Article

References (16)

1. Centers for Disease Control. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid. Mortal. Weekly Rep. 46:765-766.
2. Centers for Disease Control. 1997. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid. Mortal. Weekly Rep. 46:813-815.
3. De Lencastre, H., and A. Tomasz. 1994. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 38:2590-2598.
4. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F.C. Tenover. 1997. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
5. Kaatz, G.W., S.M. Seo, N.J. Dorman, and S.A. Lerner. 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
6. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680-685.
7. Pinho, G.M., H. deLencastre, and A. Tomasz. 1998. Transcriptional analysis of the Staphylococcus aureus Penicillin Binding Protein 2 Gene. J. Bacteriol. 180:6077-6081.
8. Schwalke, R.S., J.T. Stapleton, and P.H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. New Engl. J. Med. 316:927-931.
9. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179: 2557-2566.
10. Sieradzki, K., and A. Tomasz. 1998. Suppression of glycopeptide resistance in a highly teicoplanin resistant mutant of Staphylococcus aureus by transposon inactivation of genes involved in cell wall synthesis. Microb. Drug Resist. 4:159-168.
11. Sieradzki, K., M.G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. (in press).
12. Sieradzki, K., R.B. Roberts, S.W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. New Engl. J. Med. 340:517-523.
13. Sieradzki K., and A. Tomasz. 1999. Gradual alterations in cell wall structure and metabolism in vanomycin-resistant mutants of Staphylococcus aureus. J. Bacteriol. (in press).
14. Tomasz, A., S. Nachman, and H. Leaf. 1991. Stable classes of phenotypic expression in methicillin resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35:124-129.
15. Wu, S., H. de Lencastre, A. Sali, and A. Tomasz. 1996. A phosphoglucomutase-like gene essential for the optimal expression of methicillin resistance in Staphylococcus aureus: molecular cloning and DNA sequencing. Microb. Drug Resist. 2:277-286.
16. Wu, S., H. de Lencastre, and A. Tomasz. 1998. Genetic organization of the mecA region in methicillin-susceptible and methicillin-resistant strains of Staphylococcus sciuri. J. Bacteriol. 180:236-242.